118 related articles for article (PubMed ID: 23719419)
1. Protein oxidation in chronic kidney disease.
Caimi G; Carollo C; Hopps E; Montana M; Lo Presti R
Clin Hemorheol Microcirc; 2013; 54(4):409-13. PubMed ID: 23719419
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte activation markers and oxidative status in chronic kidney disease.
Carollo C; Lo Presti R; Caimi G
Minerva Urol Nefrol; 2013 Mar; 65(1):69-76. PubMed ID: 23538312
[TBL] [Abstract][Full Text] [Related]
3. Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treatment.
Caimi G; Carollo C; Montana M; Vaccaro F; Lo Presti R
Clin Hemorheol Microcirc; 2009; 43(3):253-8. PubMed ID: 19847059
[TBL] [Abstract][Full Text] [Related]
4. Effect of haemodialysis on the oxidative stress and antioxidants in diabetes mellitus.
Dursun E; Dursun B; Suleymanlar G; Ozben T
Acta Diabetol; 2005 Oct; 42(3):123-8. PubMed ID: 16258735
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.
Caimi G; Carollo C; Montana M; Iatrino R; Bondì B; Lo Presti R
Blood Purif; 2009; 27(2):194-8. PubMed ID: 19153478
[TBL] [Abstract][Full Text] [Related]
6. Does dialysis modality influence the oxidative stress of uremic patients?
Capusa C; Stoian I; Rus E; Lixandru D; Barbulescu C; Mircescu G
Kidney Blood Press Res; 2012; 35(4):220-5. PubMed ID: 22223182
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.
Wu CC; Chen JS; Wu WM; Liao TN; Chu P; Lin SH; Chuang CH; Lin YF
Nephrol Dial Transplant; 2005 Jun; 20(6):1134-9. PubMed ID: 15814542
[TBL] [Abstract][Full Text] [Related]
8. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and other risk factors for white matter lesions in chronic hemodialysis patients.
Muñoz-Cortés M; Cabré C; Villa D; Vives JP; Arruche M; Soler J; Compte MT; Aguilera J; Jariod M; Romeu M; Giralt M; Martinez-Vea A
Clin Nephrol; 2013 Sep; 80(3):187-97. PubMed ID: 23743154
[TBL] [Abstract][Full Text] [Related]
10. Protein thiol oxidation and lipid peroxidation in patients with uraemia.
Prakash M; Upadhya S; Prabhu R
Scand J Clin Lab Invest; 2004; 64(6):599-604. PubMed ID: 15370466
[TBL] [Abstract][Full Text] [Related]
11. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function and oxidative stress in chronic kidney disease of varying severity and the effect of acute hemodialysis.
Khaira A; Mahajan S; Kumar A; Saraya A; Tiwari SC; Prakash S; Gupta A; Bhowmik D; Agarwal SK
Ren Fail; 2011; 33(4):411-7. PubMed ID: 21529270
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction and oxidative stress in chronic renal failure.
Ghiadoni L; Cupisti A; Huang Y; Mattei P; Cardinal H; Favilla S; Rindi P; Barsotti G; Taddei S; Salvetti A
J Nephrol; 2004; 17(4):512-9. PubMed ID: 15372412
[TBL] [Abstract][Full Text] [Related]
14. Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
Capeillère-Blandin C; Gausson V; Nguyen AT; Descamps-Latscha B; Drüeke T; Witko-Sarsat V
Nephrol Dial Transplant; 2006 Jun; 21(6):1555-63. PubMed ID: 16476719
[TBL] [Abstract][Full Text] [Related]
15. Elastase, α1-proteinase inhibitor, and interleukin-8 in pre-dialyzed and hemodialyzed patients with chronic kidney disease.
Polańska B; Augustyniak D; Makulska I; Niemczuk M; Zwolińska D; Jankowski A
Pediatr Int; 2010 Oct; 52(5):735-43. PubMed ID: 20487365
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation on dialysis membranes.
Zima T; Haragsim L; Stípek S; Bártová V; Nĕmecek K
Biochem Mol Biol Int; 1993 Mar; 29(3):531-7. PubMed ID: 8485468
[TBL] [Abstract][Full Text] [Related]
17. Carbonyl stress in chronic renal failure: the effect of haemodialysis.
Dursun E; Dursun B; Süleymanlar G; Ozben T
Ann Clin Biochem; 2005 Jan; 42(Pt 1):64-6. PubMed ID: 15802036
[TBL] [Abstract][Full Text] [Related]
18. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease.
Sela S; Shurtz-Swirski R; Cohen-Mazor M; Mazor R; Chezar J; Shapiro G; Hassan K; Shkolnik G; Geron R; Kristal B
J Am Soc Nephrol; 2005 Aug; 16(8):2431-8. PubMed ID: 15987755
[TBL] [Abstract][Full Text] [Related]
19. Effects of peritoneal-and hemodialysis on levels of plasma protein and lipid oxidation markers in diabetic patients.
Sozer V; Korkmaz Guntas G; Konukoglu D; Dervisoglu E; Gelisgen R; Tabak O; Kalender B; Uzun H
Minerva Med; 2013 Feb; 104(1):75-84. PubMed ID: 23392540
[TBL] [Abstract][Full Text] [Related]
20. Human erythrocyte delta-aminolevulinate dehydratase activity and oxidative stress in hemodialysis patients.
Valentini J; Schmitt GC; Grotto D; Santa Maria LD; Boeira SP; Piva SJ; Brucker N; Bohrer D; Pomblum VJ; Emanuelli T; Garcia SC
Clin Biochem; 2007 Jun; 40(9-10):591-4. PubMed ID: 17462617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
